Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician’s choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer

Kan Yonemori; Keiichi Fujiwara; Kosei Hasegawa; Mayu Yunokawa; Kimio Ushijima; Shiro Suzuki; Ayumi Shikama; Shinichiro Minobe; Tomoka Usami; Jae-weon Kim; Byoung-gie Kim; Peng-hui Wang; Ting-chang Chang; Keiko Yamamoto; Shirong Han; Jodi Mckenzie; Robert J. Orlowski; Takuma Miura; Vicky Makker; Yong Man Kim

대한부인종양학회 Journal of Gynecologic Oncology (JGO) Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician’s choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer

Candidate SCIE SCOPUS

( Kan Yonemori ) , ( Keiichi Fujiwara ) , ( Kosei Hasegawa ) , ( Mayu Yunokawa ) , ( Kimio Ushijima ) , ( Shiro Suzuki ) , ( Ayumi Shikama ) , ( Shinichiro Minobe ) , ( Tomoka Usami ) , ( Jae-weon Kim ) , ( Byoung-gie Kim ) , ( Peng-hui Wang ) , ( Ting-chang Chang ) , ( Keiko Yamamoto ) , ( Shirong Han ) , ( Jodi Mckenzie ) , ( Robert J. Orlowski ) , ( Takuma Miura ) , ( Vicky Makker ) , ( Yong Man Kim )

대한부인종양학회 2024.03

Journal of Gynecologic Oncology (JGO) vol. 35 iss. 2 1-13(13pages)

More

Cite Copy URL Bookshelf

* This article cannot be purchased.

Preview

Abstract

Keywords

Table of Contents

INTRODUCTION
MATERIALS AND METHODS
DISCUSSION
ACKNOWLEDGEMENTS
SUPPLEMENTARY MATERIALS
REFERENCES

References (0)

[자료제공 : 네이버학술정보]